Observational study on classic infectious diseases

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study collects and analyzes clinical specimens from patients diagnosed with classic infectious diseases such as brucellosis, epidemic hemorrhagic fever, and kala-azar. It aims to investigate the epidemiological distribution and treatment options for these diseases in China. The study focuses on real-world data to understand the current trends and challenges associated with these infections. By examining patient samples and clinical data, the research seeks to provide insights into effective management strategies for these conditions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

Brucellosis： Patients with any of the following confirmed the evidence.

1. sample culture: Brucella;
2. Specific antigen or antibody (IgG or IgM) positive. epidemic hemorrhagic fever：

1 specific antibody positive 2 Hantavirus RNA positive kala-azar：

1. latent infection: rK39 antibody positive
2. patients with the following evidence of kala-azar diagnosis: 1) bone marrow, spleen puncture sample culture: Leishmania; 2) bone marrow, spleen puncture sample smear: Leishmania; 3) clinical symptoms, history of exposure or epidemiology, and positive screening test (rK39 positive)

Exclusion Criteria:

1. Patient history data is incomplete
2. HIV antibody positive and AIDS patients
3. Patients who participated in other clinical trials during the same period.
4. Pregnant, lactating women or women of childbearing age who are ready to conceive.

Where it's running

• Huashan Hospital of Fudan University
  Shanghai, Shanghai Municipality, China Recruiting

Study contacts

• Study coordinator: JingWen Ai, Doctor
• Email: jingwenai1990@126.com
• Phone: +86 13764990804

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Short-Course TB Treatment for Children with Non-Severe Pulmonary TB

  This trial tests two shorter-treatment options for kids with non-severe pulmonary TB to see if they can clear the infection as well as the standard 6-month plan.

  Recruiting at 13 sites Phase 2 Huashan Hospital · Fuzhou, Fujian and 12 other locations · NCT07893444

• Niaoduqing Granules for Older Adults with Kidney Function Decline

  This study tests whether Niaoduqing Granules can slow kidney decline and improve nutrition and frailty in adults over 60 with non-dialysis chronic kidney disease.

  Recruiting Phase 4 Huashan Hospital · Shanghai, Shanghai Municipality · NCT07741292

• Enarodustat for Anemia in Non-Dialysis CKD Patients

  This study tests whether enarodustat can help increase hemoglobin safely in adults with CKD who aren’t on dialysis, grouping participants by inflammation level.

  Recruiting Huashan Hospital · Shanghai, Shanghai Municipality · NCT07741279

• Gastric and pancreatic cancer patients see if IR199 with Ga-68 and I-131 is safe and how it distributes in the body

  This study tests the safety and how the radio-labeled IR199 distributes in the body of adults with Claudin 18.2-positive gastric or pancreatic cancer.

  Recruiting Early Phase 1 Huashan Hospital · Shanghai · NCT07707531

• Clinical Multimodal Surveillance of Respiratory Pathogens

  This nationwide study tests a hospital-based system to track respiratory pathogens in patients with respiratory symptoms and to use samples collected during care to spot trends and support prevention efforts.

  Recruiting at 31 sites Huashan Hospital · Beijing, Beijing Municipality and 30 other locations · NCT07694648

• Infection and Immune Aging in Older Adults: A Look at How Immunosenescence Relates to Infections

  This study will follow people aged 60 and up to see how aging immune systems relate to infections, comparing healthy seniors with those who have infections.

  Recruiting Huashan Hospital · Shanghai, Shanghai Municipality · NCT07672522

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.